Literature DB >> 23771465

Prevalence of β thalassemia carrier state in Sindhi community of Wardha and evaluation of risk factors for β thalassemia trait.

R Rakholia1, P Chaturvedi.   

Abstract

OBJECTIVE: To determine the prevalence of β thalassemia in Sindhi community of Wardha and evaluation of risk factors. To give genetic counseling to those diagnosed as carriers. STUDY
DESIGN: Cross-sectional (prevalence study).
SETTING: Sindhi community residing in and around Wardha. STUDY PERIOD: 18 months.
MATERIALS AND METHODS: A total of 578 individuals belonging to Sindhi community residing in and around Wardha in India were selected by systemic randomization. Those who fulfilled the inclusion criteria and voluntarily gave consent were subject to Naked Eye Single Tube Rapid Osmotic Fragility Test (Nestroft). Those found positive by Nestroft were labeled carriers and advised to undergo Hemoglobin A 2 (HbA 2 ) quantification for confirmation of carrier status. Carriers thus identified were given genetic counseling. RESULT: The mean age of study population was 15.06 years with a range of 3-28 years. The largest group consisted of those between 12 and 18 years. The prevalence of β thalassemia carrier state as diagnosed by Nestroft is 36.36% (200/550) and incidence of carrier state by HbA 2 quantification in the study population was 17.2% (95/550).
CONCLUSION: Prevalence of β thalassemia in the Sindhi community of Wardha is higher than in other studies and equal to the highest prevalent communities in India. Thus, we recommend that urgent measures to increase awareness and control the disease be taken.

Entities:  

Mesh:

Year:  2013        PMID: 23771465     DOI: 10.4103/1119-3077.113468

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  1 in total

1.  NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.

Authors:  Manasi Gosavi; Ramesh Chavan; M B Bellad
Journal:  J Lab Physicians       Date:  2021-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.